TINGSN Sonic Eyes 10: China's First Domestically Developed Intracardiac Echocardiography (ICE) Catheter by TINGSN Technologies

Intracardiac Echocardiography (ICE)Refers toMount the miniature transducer at the catheter tip, deliver it to the heart chamber via the femoral vein, emit sound waves from the transducer, and then process the received echoes through a computer to form an ultrasound image., which can provide high-resolution real-time imaging of the internal anatomical structures of the heart chambers, as well as other catheters and devices within the heart chambers, and real-time monitoring of hemodynamic status. Unlike traditional ultrasound technology, intracardiac ultrasound hasHigh imaging quality, strong real-time performance, nearly 360-degree observabilityand other features, which can better assess cardiac function and pathological conditions. At the same time, doctors can more accurately identify lesion locations, determine the optimal surgical plan, and improve the success rate and outcomes of the surgery.

ICE integrates multi-dimensional cutting-edge technologies such as material development, transducer design, catheter packaging, precision mechanical transmission, and imaging algorithms.Among them, the core technology is monopolized by only a few foreign giants.. Intracardiac echocardiography products overseas began to be widely used in clinical practice after being approved by the FDA in 1999.

In order to break through foreign technical monopolies, Jiangsu TINGSN Technology Co., Ltd. ("TINGSN") has invested nearly 300 million yuan in research and development funds since 2019. It has introduced dozens of returned overseas Ph.D.s and top domestic R&D talents, establishing a complete R&D and production team covering transducer R&D, chip design and processing, bonding process development, ultrasound imaging algorithm development, and ultrasound modeling and navigation algorithm development. From the probe, steerable catheter to the mainframe system,Establish a completeHigh-tech Barrier Closed-loop Ecosystem; Through large-scale investment in high-end hardware equipment and high-precision automated production control,AchieveLow Cost, High PerformanceProduct Advantages, in order to cope with the fierce market competition in China and strategic arrangements for going overseas.

In November last year, TINGSN produced the "TINGSN Sonic Eyes 10, a disposable intracardiac echocardiography diagnostic catheter."Successfully PassedNMPA Innovative Product Registration Application，Becomes the first high-end intracardiac echocardiography diagnostic catheter independently developed and approved in China.。

On May 20 (Monday) at 19:30, the 60th issue of VCBeat's New Product Review is honored to inviteZhang Dongyu, Chairman of TINGSN, and Xu Yong, Director of the Regulatory Affairs Center of TINGSN, bringThe First China-Made Intracardiac Ultrasound Diagnostic CatheterProduct Promotion.

China's First Self-Developed Intracardiac Ultrasound Products TINGSN Sonic Eyes 10 and TINGSN FINDERS 1

01 Disposable Intracavitary Ultrasound Diagnostic Catheter TINGSN Sonic Eyes 10;

02 Portable Color Ultrasound Diagnostic System TINGSN FINDERS 1

No general anesthesia required, significantly reduces X-ray exposure or the use of contrast agents.

Unidirectional over 160°, 360° observation of cardiac structures

Soft at the distal end, easy to bend

Rounded tip, protecting the heart

64-element phased array probe

4.5MHz-9.5MHz Multi-Frequency Switching

>41℃ automatic stop working

Avoid the risk of injury due to excessively high temperatures during clinical use.

Catheter Body IPX8 Waterproof

The catheter enters the heart chamber through the femoral vein and the inferior vena cava.

Imaging is not affected by factors such as emphysema, chest deformities, or obesity.

Close-up Direct View and High-precision Imaging

Real-time observation of important cardiac structures to avoid damage

Real-time Surgical Assessment Guidance

Monitor the pericardium to ensure safety

Protecting the Health of Doctors and Patients

High-risk groups such as pregnant women benefit more from radiation.

Performed under local anesthesia, patients recover quickly.

Single-operator procedure, without the need for multi-disciplinary coordination

Scan the QR code on the poster to add the assistant and schedule a live broadcast.

Zhang Dongyu, Chairman of TINGSN

Co-founded Weibu 3D in 2013, transforming it into the largest comprehensive 3D printing supplier in China;

Founded TINGSN in 2019, successfully launching China's first 2D ICE product;

With over 10 years of cross-industry entrepreneurial experience, possessing complete experience in building a team from scratch;

With extensive and outstanding experience in product development, marketing, and operations management.

Xu Yong, Director of the Regulatory Affairs Center at TINGSN Technology

With over 15 years of experience in the field of medical device regulatory registration;

Previously held positions at GE Healthcare and Philips Healthcare, serving as the Regulatory Registration Manager. Responsible for global regulatory registration of GE Healthcare's ultrasound products and Philips Healthcare's CT products.

Accumulated completion of NMPA registration for more than 15 Class III/Class II active and non-active products;

Completed CE and FDA registration for more than 10 products.

Jiangsu TINGSN Technology Co., Ltd. was established in 2019, focusing on the research and development of surgical instruments for intracardiac electrophysiology and structural heart disease. The company has formed R&D teams in both China and the United States, with over a hundred full-time employees; it closely collaborates with the Acoustics Institute of Nanjing University, Fuwai Hospital of the Chinese Academy of Medical Sciences, Jiangsu Provincial People's Hospital, and the electrophysiology team at the University of Pennsylvania in the United States; it possesses an integrated R&D center and manufacturing center covering nearly 4,800 square meters that combines industry, academia, research, and medicine; it has cumulatively completed over 200 million yuan in financing and was named a potential unicorn enterprise in Jiangsu Province in 2023.

"VCBeat New Product Review," is a live broadcast column under "VCBeat" that supports the release of innovative medical products. The column's mission is: to assist in the milestone release of every medical innovation product.

Scan the QR code below to contact the assistant and schedule a live broadcast.

(If already added, please proactively inquire with the assistant.)